Rarity of genomic instability in pathogenesis of systemic anaplastic large cell lymphoma (ALCL) in immunocompetent

K B Hodges1, C L Vnencak-Jones, R S Larson

  • 1Department of Pathology, Vanderbilt University Medical Center, Nashville, TN, USA.

Human Pathology
|February 24, 1999
PubMed

Insights

Microsatellite instability (MSI) does not appear to be a significant factor in the development of most systemic anaplastic large cell lymphomas (ALCL) in immunocompetent individuals. This suggests distinct biological pathways for different lymphoma subtypes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Microsatellite instability (MSI) is a genetic alteration linked to DNA mismatch repair defects and cancer development.
  • While MSI is implicated in various malignancies, its role in non-Hodgkin's lymphoma (NHL), particularly ALCL, is not well-defined.
  • Previous studies suggest MSI involvement in certain T-cell lymphomas, including those in immunocompromised patients and specific CD30+ cutaneous lymphomas.

Purpose of the Study:

  • To investigate the presence and significance of MSI in systemic T-cell ALCL occurring in immunocompetent patients.
  • To determine if defects in the DNA mismatch repair system contribute to the pathogenesis of systemic ALCL.
  • To provide molecular insights into the distinct biological processes underlying different ALCL subgroups.

Main Methods:

  • Analysis of five well-characterized cases of systemic T-cell ALCL from immunocompetent patients.
  • Extraction of genomic DNA from paired normal and tumor tissues.
  • Examination of seven microsatellite loci for MSI and loss of heterozygosity (LOH) using polymerase chain reaction (PCR).

Main Results:

  • No evidence of microsatellite instability (MSI) was detected in any of the analyzed systemic ALCL cases.
  • Loss of heterozygosity (LOH) was also not identified in the tumor samples.
  • These findings indicate that DNA mismatch repair system abnormalities are unlikely to be a major driver in the pathogenesis of most systemic ALCL.

Conclusions:

  • The study suggests that microsatellite instability does not play a significant role in the development of systemic T-cell ALCL in immunocompetent individuals.
  • The absence of MSI and LOH supports the hypothesis that different lymphoma subtypes with ALCL morphology represent distinct biological entities.
  • Further molecular investigations are warranted to elucidate the specific pathways involved in systemic ALCL pathogenesis.

Related Concept Videos

Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...